We are live on ! Find out more
EHI

Eagle Health Investments Portfolio holdings

AUM $603M
1-Year Est. Return 111.06%
This Fund
S&P 500
This Quarter Est. Return
-9.25%
1 Year Est. Return
+111.06%
3 Year Est. Return
+240.87%
5 Year Est. Return
+290.92%
10 Year Est. Return
–
AUM
$429M
AUM Growth
+$23.1M
Cap. Flow
+$82.2M
Cap. Flow %
19.17%
Top 10 Hldgs %
64.97%
Holding
32
New
4
Increased
12
Reduced
3
Closed
4

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$31.3M
2
OM icon
Outset Medical
OM
+$19.8M
3
ISRG icon
Intuitive Surgical
ISRG
+$15.4M
4
TXG icon
10x Genomics
TXG
+$13.6M
5
DXCM icon
DexCom
DXCM
+$7.44M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$21.4M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$4.28M
3
AZN icon
AstraZeneca
AZN
+$4.11M
4
ARGX icon
argenx
ARGX
+$3.09M
5
KYMR icon
Kymera Therapeutics
KYMR
+$1.57M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGEN
1
DELISTED
Seagen Inc. Common Stock
SGEN
$46.4M 10.83%
262,502
+32,000
+14% +$4.61M
HUM icon
2
Humana
HUM
$46.3B
$37.5M 8.75%
80,191
+2,300
+3% +$1.02M
UTHR icon
3
United Therapeutics
UTHR
$22.7B
$37.5M 8.75%
159,238
– –
IQV icon
4
IQVIA
IQV
$39.8B
$27.4M 6.38%
126,095
+14,100
+13% +$3.06M
AZN icon
5
AstraZeneca
AZN
$251B
$25.3M 5.9%
191,533
-31,300
-14% -$4.11M
ARGX icon
6
argenx
ARGX
$54.2B
$22.8M 5.33%
60,300
-9,600
-14% -$3.09M
ILMN icon
7
Illumina
ILMN
$29B
$22M 5.12%
+122,443
New +$31.3M
ALNY icon
8
Alnylam Pharmaceuticals
ALNY
$29B
$21.8M 5.08%
149,380
+18,136
+14% +$2.57M
NTRA icon
9
Natera
NTRA
$45.9B
$20.2M 4.72%
570,994
+123,500
+28% +$4.57M
DXCM icon
10
DexCom
DXCM
$33.1B
$17.7M 4.12%
237,100
+81,500
+52% +$7.44M
INSP icon
11
Inspire Medical Systems
INSP
$1.73B
$17.2M 4.01%
94,153
+17,900
+23% +$3.57M
CANO
12
DELISTED
Cano Health, Inc.
CANO
$16.7M 3.9%
38,167
+8,616
+29% +$4.49M
AMWL icon
13
American Well
AMWL
$231M
$16.2M 3.77%
187,071
-3,479
-2% -$260K
OM icon
14
Outset Medical
OM
$91.4M
$15.1M 3.53%
67,931
+45,998
+210% +$19.8M
AXNX
15
DELISTED
Axonics, Inc. Common Stock
AXNX
$14.5M 3.39%
256,465
– –
ISRG icon
16
Intuitive Surgical
ISRG
$139B
$13.2M 3.07%
+65,530
New +$15.4M
AGIO icon
17
Agios Pharmaceuticals
AGIO
$1.95B
$12.8M 2.98%
576,413
+145,000
+34% +$3.28M
TXG icon
18
10x Genomics
TXG
$7.44B
$11.8M 2.76%
+261,200
New +$13.6M
ADPT icon
19
Adaptive Biotechnologies
ADPT
$4.05B
$9.83M 2.29%
1,214,860
+200,000
+20% +$1.76M
BPMC
20
DELISTED
Blueprint Medicines
BPMC
$8.62M 2.01%
170,551
– –
GH icon
21
Guardant Health
GH
$22.4B
$6.13M 1.43%
151,960
– –
CMAX
22
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$2.6M 0.61%
23,825
– –
FDMT icon
23
4D Molecular Therapeutics
FDMT
$582M
$1.82M 0.43%
261,423
+129,333
+98% +$1.26M
BEAM icon
24
Beam Therapeutics
BEAM
$2.82B
$1.12M 0.26%
28,900
– –
ARVN icon
25
Arvinas
ARVN
$588M
$968K 0.23%
23,000
– –
1
2

Similar funds

IECM
Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return
ERWM
Elk River Wealth Management Denver, Colorado $602M AUM 22.77% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $602M AUM 165.22% 1-Year Est. Return
JHCP
Jackson Hole Capital Partners Tulsa, Oklahoma $605M AUM 22.77% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
OCAM
Onex Canada Asset Management Toronto, Ontario, Canada $601M AUM 15.16% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

Eagle Health Investments's Q2 2022 Portfolio in Review

As of Q2 2022, Eagle Health Investments held 32 positions worth $429M, up 5.7% from $406M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Eagle Health Investments deployed $82.2M of net new capital in Q2 2022, opening 4 new positions and adding to 12 existing holdings. Its largest new stake was Illumina: 122,443 shares worth $22M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was AstraZeneca, an estimated $4.11M trimmed.

  • Eagle Health Investments's largest Q2 2022 buy was Illumina: 122,443 shares worth $22M.
  • Eagle Health Investments added most to Outset Medical in Q2 2022, an estimated $19.8M increase.
  • Eagle Health Investments's biggest Q2 2022 reduction was AstraZeneca, cutting an estimated $4.11M.
  • Eagle Health Investments fully exited Vertex Pharmaceuticals in Q2 2022, selling an estimated $21.4M.
  • Eagle Health Investments's ten largest holdings make up 65% of its $429M portfolio in Q2 2022.
  • Eagle Health Investments opened 4 new positions and closed 4 in Q2 2022.
  • Eagle Health Investments's portfolio value rose 5.7% quarter-over-quarter to $429M.

Based on Eagle Health Investments's 13F filing for Q2 2022, filed 11 Aug 2022.